IGF-LR3 + BPC-157 [Peptide]

Description

About IGF-LR3 + BPC-157 Peptide Blend

IGF-1 LR3 (Insulin-like Growth Factor-1 Long Arg3) and BPC-157 (Body Protection Compound-157) are two synthetic peptides. BPC-157 is a simple linear peptide. Whereas, IGF-1 LR3 belongs to a family of growth factor peptides that have a complicated chemical structure.

The blend consists of 1 mg IGF-LR3 and 5 mg BPC-157, totaling 6 mg. The Peptide Blend is also offered with the option of BPC 157 Arg, valued for its enhanced stability and resistance to breakdown, making it a stronger choice for research.

Overview of IGF- LR3

IGF-LR3 is a synthetic modified version of IGF. IGF-LR3 has LR3 attached to it for bioavailability and sensitivity. It consists of 83 amino acids, with 70 from the native IGF-1 structure and an additional 13 from the LR3 extension. Moreover, it has two primary alterations:

• A substitution of arginine for glutamic acid at the 3rd position
• The addition of a 13–amino acid extension at the N-terminal

IGF LR3 is a potent growth agent. Researchers are investigating this compound for its possible effects on muscle growth, recovery, weight management, and endurance.

Overview of BPC-157 

BPC-157 is a pentadecapeptide that consists of 15 amino acids. It is derived from a partial sequence of a protein found in gastric juice. 

In different research models, the peptide has been shown to help with anti-inflammatory properties and healing. It is also believed to influence processes like angiogenesis, collagen production, and cellular repair. 

Researchers explore IGF-LR3 + BPC-157 stack for its potential to support cell growth, promote tissue repair, improve muscle mass, and enhance recovery. In different research models, the combination of these peptides has been shown to amplify the results. 

Working Mechanism of IGF-1 LR3 + BPC-157 Peptide Blend

IGF-LR3+ BPC-157 works synergistically to produce powerful results in research subjects. Here is a quick breakdown of their work: 

IGF-LR3: 

IGF-LR3 is an extended version of IGF-1 that may last longer in the research models. The reason why it stays longer is that it shows resistance to insulin-like growth factor binding proteins (IGFBPs).

The peptide attaches to IGF-1 receptors on cells, as observed in laboratory settings. By doing so, it may activate a few pathways, including PI3K-Akt and MAPK/ERK. These pathways may promote cell growth, protein production, and muscle repair in research subjects. 

Besides that, IGF-LR3 appears to help research models use glucose efficiently and supports nerve and blood vessel health. This ultimately makes IGF-LR3 a potent peptide for tissue regeneration and growth in environmental settings. 

BPC-157: 

BPC-157 is thought to work by modulating VEGF (vascular endothelial growth factor) and nitric oxide signaling in research subjects. This may influence the angiogenic and cytoprotective pathways. 

Both VEGF and nitric oxide play a vital role in supporting blood vessel formation. This interestingly supports blood vessel formation, collagen synthesis, and tissue health in lab models.  

Combined Action: 

The combination of IGF-LR3 + BPC-157 offers dual action with more potency in research subjects. While IGF-LR3 enhances cell multiplication and muscle growth, BPC-157 may boost tissue repair and vascularization. 

Potential Benefits | IGF-LR3 + BPC-157 Peptide

Researchers have observed the following benefits of IGF-R3 + BPC-157 in various laboratory settings. 

• It may promote muscle growth and protein synthesis in research subjects.
• It may enhance tissue repair and wound healing in research models.
• May support nerve regeneration and vascular health in clinical studies.
• May improve glucose uptake and metabolic efficiency in research subjects.
• It may reduce inflammation and oxidative stress in research models.
• May accelerate recovery from injuries in clinical studies.

Potential Side Effects of | IGF-LR3 + BPC-157 Peptide

Long-term research is needed to understand the safety profile of this compound. However, so far, researchers have observed the following side effects of the IGF-LR3+BPC-157  peptide.

• May cause water retention and edema in research subjects.
• It may lead to mild joint or muscle pain in research models.
• Potential risk of hypoglycemia in clinical studies.
• Possible headaches or fatigue in research subjects.
• Rare gastrointestinal discomfort in research models.
• Unknown long-term effects in clinical studies.

Where to Buy IGF-LR3 + BPC-157 Peptide?

Out of many online shops, RCDBio stands out due to its transparency and commitment to quality. We provide you with the finest quality, third-party tested IGF-LR3+BPC-157 stack at unbeatable prices.  In addition to that, we offer a Certificate of Analysis with all our products. Moreover, we are 24/7 available for your help. Plus, we offer secure transaction options to ensure you have a safe and better shopping experience. 

FAQs

Is IGF-LR3 + BPC-157 toxic?

In research subjects, the IGF-LR3+BPC-157 blend has shown low toxicity at standard doses. However,  long-term safety data are limited in research models.

How stable is IGF-LR3 + BPC-157?

In research models, both peptides are relatively stable when stored properly (refrigerated, away from light). However, IGF-LR3 is more sensitive to heat.

How does IGF-LR3 + BPC-157 peptide degradation occur?

In clinical studies, peptides degrade over time due to enzymatic activity and improper storage, both of which reduce their potency.

Disclaimer

IGF-LR3 + BPC-157 is exclusively for laboratory research purposes. RCD bio products are not intended to diagnose, treat, or cure any disease. 

The Food and Drug Administration has not evaluated the statements on our website. Researchers must comply with all applicable local laws and regulations. By purchasing, you agree to our Terms and Conditions. In addition, RCDbio reserves the right to refuse sales to unauthorized individuals. 

For queries, complaints, or support, contact support@rcdbio.co.